-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
As Canopy Growth Stock Stalls, Pot Investors Mull What Will Happen Next?
Canopy Growth faces plenty of tough problems ahead. So too, do its competitors. When will outsized growth return to CGC?
We’re One Step Closer to the Ultimate Catalyst for Cannabis Stocks
Even as stocks are under pressure, cannabis continues to proceed down the path toward full legalization. It is closer now than ever.
Here’s How to Trade Aphria Stock Without Getting Smoked
If you’re looking for a cannabis standout off and on the price chart, Aphria stock is delivering in more than one way for investors.
Aphria Stock Has the Best Chances of Soaring High in the Pot Market
Aphria has a strong brand, independent management and plenty of cash on the books to fund its expansion. How will Aphria stock fare next?
The Manitoba Harvest Acquisition Saved Tilray Stock This Quarter
Tilray’s acquisition of Manitoba Harvest should help Tilray stock. TLRY stock may perform better than other marijuana stocks.
Investors Can Still Get High on American Marijuana Stocks
Tune into 'Moneyline' with Matt McCall for more on CRON stock, other cannabis plays and three under-the-radar stocks you should watch.
Will It Get Worse Before It Gets Better for Hexo Stock?
As HEXO stock has overpromised and underdelivered in recent months. the Hexo stock price has declined very rapidly.
‘Cannabis 2.0’ May Not Be Enough to Save Canopy Growth Stock
"Cannabis 2.0" could be the catalyst to save CGC stock. But other factors remain at play. Tread carefully before buying Canopy Growth stock.
Why Aurora Cannabis Stock Isn’t Worth a Hit Before Earnings
Don’t expect Aurora Cannabis to pull an ace from its sleeve when it reports earnings this evening. Here's why ACB stock should be avoided.
Q3 Numbers Show Why Cronos Stock May Not Rebound in the Short Term
CRON stock will head way higher in the long run. But, the long-term rebound won't start until today's weak profit trends improve.
Tilray Stock Has Fallen and Can’t Get Up
Tilray stock, along with the rest of the marijuana sector, have fallen out of favor and won't get back up. They need consistent profit.
Don’t Expect Much From Aurora Cannabis Stock’s Upcoming Report
ACB stock is set to fall much further. Aurora can't make money because of lower selling prices, overspending and its huge cash burn.
3 Pros, 3 Cons for New Age Beverages Stock
NBEV stock has the potential to dominate the CBD-infused beverages market. But legal and competitive problems shouldn’t be ignored.
What to Expect From Aurora Cannabis Stock Ahead of Earnings
With much of its debt coming due in March, ACB stock will need to calm investors' worries about dilution on this quarter's earnings call.
Aphria Stock Will Reward Patient Investors
Aphria stock has declined in recent months along with its peers, but an eventual recovery by APHA should reward patient investors.
Why I Changed My Mind About Canopy Growth Stock
Canopy Growth stock is one of the four big Canadian pot companies that will report results for the quarter ended Sept. 30 this week and Street expectations aren't optimistic.
With Huge Cash Burn, Canopy Growth Stock Is Set to Fall Further
With its huge cash burn, Canopy Growth stock is set for further downside. Short sellers are raising their bets on CGC.
High Hopes: Tilray Stock Needs a Miracle to Finish 2019 Strong
Investors justifiably have low expectations for TLRY stock ahead of quarterly earnings. Here's the outlook for Tilray through the end of 2019.
